Category Archives: – Policy

Senate Finance Committee hearing on CMMI

August 15, 2013

Posted in CMS, Congress | Leave a comment

Exclusive: CEO of Komen for the Cure never stepped down as announced in 2012

June 6, 2013- By Steven E. Greer, MD The breast cancer research foundation Komen for the Cure, founded by Nancy Brinker, got into hot water in 2012

Posted in - Policy, Oncology | Leave a comment

FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs

Interviewed by Steven E. Greer, MD

Posted in - Pharma, FDA | Leave a comment

What happens next with the ACA law?

May 20, 2013- Interviewed by Steven E. Greer, MD

Posted in CMS, Congress | Leave a comment

Reasons for permanent slowdowns in healthcare spending growth

May 17, 2013- Interviewed by Steven E. Greer, MD Since 2010,

Posted in CMS, Harvard | Leave a comment

Renal denervation devices to treat hypertension

William O’Neill, MD of Henry Ford Hospital discusses renal denervation devices used to treat refractory hypertension. He is involved with the Medtronic device trials.

Posted in - Medical Devices, Cardiology, FDA, Henry Ford | Leave a comment

The Massachusetts General trauma response to the Boston bombings

May 3, 2013- Interviewed by Steven E. Greer, MD Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General

Posted in - NEJM, - Policy, Trauma Surgery | Leave a comment

How Boston medical centers prepare for unconventional weapon attacks

May 3, 2013- Interviewed by Steven E. Greer, MD Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General

Posted in - Policy, Boston University, CDC, Congress, Emergency medicine, Harvard, Trauma Surgery | Leave a comment

How Boston medical centers prepare for unconventional weapon attacks

May 3, 2013- Interviewed by Steven E. Greer, MD

Posted in - Policy, Boston University, Emergency medicine, Harvard, Trauma Surgery | Leave a comment

FDA official, William Maisel, pleads guilty to crime, keeps job

April 24, 2013 By Steven E. Greer, MD In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal

Posted in - Medical Devices, FDA | Leave a comment

Smartphone apps to be regulated and taxed as medical devices

March 26, 2013 Which smartphone apps will the FDA label as a medical device making them taxable tax under

Posted in - Medical Devices, Congress, FDA | Leave a comment

The IOM report on counterfeit and substandard drugs

Prashant Yadav, PhD, Director, Health Care Research Initiative, University of Michigan, discusses

Posted in - Policy, Univ Michigan | Leave a comment

High fructose consumption and fatty liver disease

Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology

Posted in Diabetes and endocrinology, Duke, FDA, Pediatrics | Leave a comment

Will medical centers be able to change leadership structure to conform to the PPACA “ObamaCare”?

June 30, 2012, by Steven Greer, MD The Supreme Court ruled that the PPACA “ObamaCare” law was constitutional in most aspects.

Posted in - Policy, Cardiology, Congress, Univ Maryland | Leave a comment

RomneyCare ballooned healthcare costs in Massachusetts

June 24, 2012 CBS News interviewed the Governor of Massachusetts, Deval Patrick, about the cost increases

Posted in CMS, Congress | Leave a comment

Pork Is Clogging CMMI’s Arteries

June 20, 2012- in the WSJ– by Steven E. Greer, MD Center for Medicare and Medicaid Innovation Director Richard Gilfillan’s reply (Letters, June 14) to my op-ed of June 5 says that my accusations “are baseless.” This was backed up … Continue reading

Posted in - Opinion, CMS | Leave a comment

Inside ObamaCare’s Grant-Making: CMMI

June 4, 2012- In the Wall Street Journal Op-Ed section– by Steven E. Greer Early this year, I was briefly involved with one of the Affordable Care Act’s bureaucracies called

Posted in - Opinion, - Policy, CMS | Leave a comment

Does Steve Nissen manipulate the media?

April 5, 2010 Opinion By Steven E. Greer, MD The New York Times recently ran a front-page story raising concern about expanding the indication for statins to people with normal cholesterol levels, per the Crestor JUPITER trial. The article mentioned … Continue reading

Posted in - Opinion, - Policy, Cardiology, Cleveland Clinic | Leave a comment

Reasons to Abandon Low-Density Lipoprotein Cholesterol Targets

Interviewed by Steven Greer, MD Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation

Posted in - Policy, Cardiology, CMS, FDA, NIH, Yale | Leave a comment

Update on the DEA’s efforts to curb the “pain pill mill” problem in Florida

March 7, 2012  By Steven Greer, MD We previously interviewed Special Agent Mark Trouville, the DEA agent in charge of tackling the rampant abuse of prescription opioid pain pills in Florida, and the “pain pill mill” system.

Posted in - Policy, Congress, Rehab | Leave a comment